Kymera Therapeutics Inc.
KYMR | NASDAQ
$120.75
+$3.08 (+2.62%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 357.01M | 120.26M | 109.97M | 68.4M | 47.98M | 31M |
Short-Term Investments | 491.27M | 368.49M | 264.92M | 338.77M | 394.44M | 265.2M |
Long-Term Investments | 776.96M | 362.16M | 61.43M | 152.33M | 125.19M | 162.53M |
Other Long-Term Assets | 9.11M | 7.74M | 7.93M | 9.15M | 8.14M | 1.62M |
Receivables | n/a | 947K | 18.76M | 2.54M | 135K | 1.43M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 22.94M | 20.58M | 11.67M | 9.71M | n/a | n/a |
Total Current Assets | 871.21M | 510.27M | 405.32M | 419.42M | 451.27M | 302.34M |
Property-Plant & Equipment | 85.53M | 97.86M | 101.08M | 22.24M | 21.31M | 20.69M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 871.6M | 467.77M | 170.44M | 183.72M | 154.63M | 184.84M |
Total Assets | 1.74B | 978.04M | 575.76M | 603.13M | 605.91M | 487.18M |
Account Payables | 4.01M | 5.99M | 7.08M | 4.34M | 4.01M | 4.37M |
Deferred Revenue | 22.93M | 13.58M | 37.88M | 35.26M | 61.74M | 92.55M |
Short-Term Debt | 13.76M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 24.21M | 223K | 23.16M | 303K | 228K | 106K |
Total Current Liabilities | 83.21M | 67.77M | 85.69M | 71.34M | 92.54M | 110.62M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 248K | 66K | 100K |
Total Long-Term Liabilities | 79.94M | 74.65M | 95.1M | 41.64M | 53.73M | 92.67M |
Total Liabilities | 163.15M | 142.42M | 180.79M | 112.98M | 146.27M | 203.29M |
Total Debt | 82.25M | 87.76M | 84.67M | 17.34M | 17.96M | 17.99M |
Book Value | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M | 283.89M |
Book Value Per Share | 18.72 | 11.14 | 6.77 | 9.09 | 9.58 | 6.37 |
Common Stock | 8K | 7K | 6K | 6K | 5K | 4K |
Retained Earnings | -1.07B | -754.61M | -530.75M | -383.79M | -228.98M | -128.77M |
Comprehensive Income | 1.8M | -1.49M | -552K | -4.95M | -660K | -128K |
Shareholders Equity | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M | 283.89M |
Total Investments | 1.27B | 730.65M | 326.35M | 491.1M | 519.63M | 427.73M |
Add to Watchlist
Select watchlists to add or remove KYMR